This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Standard Chartered PLC | 646.0 | 4.4% |
| Persimmon PLC | 1,274.0 | 3.4% |
| Barclays PLC | 157.9 | 3.2% |
| HSBC Holdings PLC | 584.3 | 3.0% |
| Kingfisher PLC | 260.9 | 2.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Hiscox LTD | 1,118.0 | -3.0% |
| Admiral Group PLC | 2,222.0 | -2.6% |
| Beazley PLC | 583.0 | -2.3% |
| National Grid PLC | 1,118.5 | -2.2% |
| Melrose Industries PLC | 166.9 | -1.9% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,872 | 0.4% | 3.4% |
| DOW JONES INDUS. AVG | 33,886 | -0.4% | -1.6% |
| DAX INDEX | 15,808 | 0.5% | 11.6% |
| NIKKEI 225 | 28,515 | 0.1% | 5.3% |
| S&P/ASX 200 INDEX | 7,382 | 0.3% | -1.9% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 82.39 | -0.16% |
| Brent Crude (ICE) | USD/bbl. | 86.18 | -0.15% |
| Gold Spot | USD/t oz. | 2,012 | 0.4% |
| Copper (Comex) | USd/lb. | 413 | 0.5% |
Click graph to enlarge
The UK 100 called to open +29 points at 7900. The UK 100 is expected to make a bright start to the week heading back towards the 7,900 mark taking encouragement from a positive set of earnings from a number of leading US banks, results from JPMorgan, Citi and Wells Fargo went some way to reassure investors that the turmoil caused by the collapse of Silicon Valley Bank had not damaged the sectors performance. Asian markets had a positive start to the week, the Nikkei 225 index was up 0.1%. In China, the Shanghai Composite was up 1.2%, while the Hang Seng index in Hong Kong was up 0.8%. On Friday, Wall Street ended the final session of the week lower, with the Dow Jones down 0.4%, the S&P 500 down 0.2% and the Nasdaq Composite down 0.4%.
Ashmore reports that their FY23 assets under management increased by $5bn. They had positive investment performance of $1.6bn, net outflows of $1.1bn.
AstraZeneca reports positive results for lung cancer drug combination.
BHP Group: An Australian court has approved BHP’s 100% acquisition of OZL.
John Wood agrees to extend the put-up-or-shut-up deadline for Apollo offer to May 17th.
Qinetiq expects their FY results to March 31st to be ahead of its expectations.
S4 Capital Chair Martin Sorrell is to continue to work “as normal” despite medical treatment.
RBC Upgrades RS Group to Outperform from Sector Perform (7 Buys / 6 Holds / 0 Sells)
UK
Ashmore Group plc
Sirius Real Estate Limited
US
None
UK
IntegraFin Holdings
Ninety One
US
Bank of America Corp
Goldman Sachs
Johnson & Johnson
Intuitive Surgical
Netflix
Chinese Gross Domestic Product
Chinese Industrial Production
Chinese Retail Sales
UK Claimant Count Change
UK ILO Unemployment Rate
EU ZEW Survey – Economic Sentiment
German ZEW Survey – Current Situation
US Building Permits
US Housing Starts
Fed's Bowman speech
UK 100 companies going ex-dividend on 20th April 2023:
Antofagasta
BAE Systems
Weir Group
Spirax-Sarco Engineering
London Stock Exchange Group
UK 250 companies going ex-dividend on 20th April 2023:
Vanquis Banking Group
Vistry Group
Quilter
Vesuvius
Ibstock
Genuit Group
Videndum
Rathbones Group
Bodycote
Drax Group
Supermarket Income REIT
Foresight Solar Fund
Hunting
Merchants Trust
Schroder Oriental Income Fund
JPMorgan American Investment Trust
Jupiter Fund Management
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.